Search Result "US-FDA."
US-FDA Approved Drugs in 2020 and 2021: A Review
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 23 Issue: 12 Year: 2023 Page: 1273-1297
Author(s):
Identification of Novel Signals Associated with US-FDA Approved Drugs(2013) Using Disproportionality Analysis
Journal: Current Drug Safety
Volume: 19 Issue: 3 Year: 2024 Page: 395-401
Author(s):
Drug Repurposing Using FDA Adverse Event Reporting System (FAERS)Database
Journal: Current Drug Targets
Volume: 25 Issue: 7 Year: 2024 Page: 454-464
Author(s):
An Audit of Black Box Warnings (BBWs) in the United States Food andDrug Administration (US-FDA) Database - A Five-Year Analysis
Journal: Current Drug Safety
Volume: 17 Issue: 1 Year: 2022 Page: 54-58
Author(s): Debdipta Bose,Nithya Gogtay,Tejusv Goel,Mahanjit Konwar
Syntheses of FDA Approved Integrase Inhibitor HIV Drugs and Improved Manufacturing using Flow Processing
Ebook: Frontiers in Clinical Drug Research: HIV
Volume: 4 Year: 2019
Author(s): Omobolanle Janet Jesumoroti,Faith Akwi,Paul Watts
Doi: 10.2174/9781681085265119040005
US FDA Warning Letters of CAPA Violations: A Review
Journal: Applied Clinical Research, Clinical Trials and Regulatory Affairs
Volume: 7 Issue: 2 Year: 2020 Page: 85-92
Author(s): Pavan Deshpande,Rutuja Agawane,Sarath C. Tatikola,Surenahalli G. Vasantharaju
FDA-approved Drugs Selected Using Virtual Screening Bind Specifically to G-quadruplex DNA
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 12 Year: 2013 Page: 2164-2173
Author(s): Daimel Castillo-Gonzalez,Gisselle Perez-Machado,Aurore Guedin,Jean-Louis Mergny,Miguel-Angel Cabrera-Perez
3D MI-DRAGON: New Model for the Reconstruction of US FDA Drug- Target Network and Theoretical-Experimental Studies of Inhibitors of Rasagiline Derivatives for AChE
Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 16 Year: 2012 Page: 1843-1865
Author(s): Francisco Prado-Prado,Xerardo Garcia-Mera,Manuel Escobar,Nerea Alonso,Olga Caamano,Matilde Yanez,Humberto Gonzalez-Diaz
A Systematic Analysis of Physicochemical and ADME Properties of All Small Molecule Kinase Inhibitors Approved by US FDA from January 2001 to October 2015
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 29 Year: 2017 Page: 3159-3184
Author(s): Zhihong O`Brien,Mehran F. Moghaddam